Maren T H
Department of Pharmacology and Therapeutics, University of Florida College of Medicine, Gainesville 32610, USA.
J Exp Zool. 1997 Dec 1;279(5):490-7.
The connection between carbonic anhydrase and the formation of aqueous humor arose in the decade 1950-1960 when a number of experiments of differing types showed that HCO3- ion catalytically formed in the ciliary process from CO2 was a principal element in the production of the aqueous. It was soon shown that inhibitors of the enzyme, given systemically, slowed HCO3- formation and sodium and fluid transport and thereby lowered intraocular flow and pressure in normal vertebrates and in patients with glaucoma. In the past 15 years successful efforts have been made to produce sulfonamide inhibitors that reach the ciliary process after local application to the cornea. The effects of locally acting sulfonamides are largely due to their amphoteric properties. They are soluble in both lipid and non-lipid media and penetrate cornea and sclera to reach ciliary process. Potency against carbonic anhydrase II is of the order of K(I) = 10(-9) M, so that topical application inhibits essentially all enzyme in the processes and is an effective nontoxic treatment for glaucoma.
碳酸酐酶与房水生成之间的联系出现在20世纪50年代至60年代这十年间,当时一系列不同类型的实验表明,在睫状体中由二氧化碳催化形成的HCO3-离子是房水生成的主要成分。很快就发现,全身给予该酶的抑制剂会减缓HCO3-的形成以及钠和液体的转运,从而降低正常脊椎动物和青光眼患者的眼内液流动和眼压。在过去15年里,人们成功研制出了局部应用于角膜后能到达睫状体的磺胺类抑制剂。局部作用的磺胺类药物的作用主要归因于它们的两性性质。它们可溶于脂质和非脂质介质,能穿透角膜和巩膜到达睫状体。对碳酸酐酶II的抑制效力约为K(I)=10(-9)M,因此局部应用基本上能抑制该过程中的所有酶,是一种治疗青光眼的有效无毒方法。